[ad_1]
“Samsung Biologics(802,000 0.00%)If we had not stopped the process and tested our products, the location would have been practically difficult ”.
In an interview with the Korea Economic Daily, Bae Hong Bae, which makes biopharmaceutical detergents for incubators (reactors), said in an interview with the Korea Economic Daily on the 23rd: “There was a mutually beneficial relationship with large companies behind the localization. successful detergent after two years of foundation “.
Established in August 2016, Viox is a company that located reactor cleaners that were all imported from abroad. Samsung Biologics and Hanmi Pharmaceutical(325,500 + 3.33%), Peptron(15,500 -2.21%) And it supplies products to various national companies. Imported detergents had the problem that it was difficult to insure the products in urgent situations due to the long period of transportation abroad.
Plumbing company produces bio cleaners
Viox is a subsidiary of Steelox that imports and sells tubes used in chemical and pharmaceutical products from abroad. There was no experience in the field of biopharmaceuticals. He entered this field with the desire to locate detergents in cooperation with Samsung Biologics.
I ran into a challenge early on. The company took advice from Samsung Biologics and turned to a company that makes semiconductor equipment cleaners. It was explained that the application would be possible because Korea is a field that dominates the global market. CEO Bae said: “I thought that the semiconductor field, which does not allow a single error, is very similar to the biopharmaceutical market.” “We have improved the cleaning agent manufacturing technology learned by paying royalties for the biological field through our own research. Said.
Building a production plant was not easy either. Samsung Biologics consulted with Viox more than 30 times and advised from the design stage of the plant in Eumseong, North Chungcheong province. They assembled their own team of consultants and worked hard to meet manufacturing standards.
As a result, Viox designed the plant in accordance with the certification standards of the US Food and Drug Administration (FDA). Good Pharmaceutical Quality and Manufacturing Management (GMP) approval was also completed.
It was useless unless the product made in the lab was tested in a real reactor. Biopharmaceuticals go through the production process of ‘cell line development and production → culture → purification → finished’. The detergent is used to clean the cells after culturing them in the reactor. This is to test if the culture medium or impurities, which are the food of the cells, have been cleaned well. The industry admits that this process must be repeated three times before it is properly tested.
Samsung Biologics tested Viox’s cleaning agent before operating the Incheon Songdo 3 plant seriously for win-win purposes. The results were also good. CEO Bae said: “Every company has its own standards on what kind of cleaning agent to use, etc. To change this, we have to stop the process and test our products, resulting in lost labor costs.”
Finally, Viox signed a contract to supply Samsung Biologics with a long-term cleaning agent starting in July 2018. Celltrion now(332,000 + 10.12%)Tests are underway for the delivery of cleaning agents and cleaning agents. CEO Bae said: “There are research results showing that the cleaning power is better or similar to that of foreign products when the same amount of cleaning agent is used for the same period of time,” he said. “Not only in Korea, we will start exporting to China and Japan.”
Samsung helped small and medium-sized businesses at risk
For Samsung Biologics, shutting down the factory and testing the products of SMEs is a considerable burden. In the process of closing the factory, you have to pay for labor and badges.
Samsung Biologics is known to have performed localization in accordance with the win-win plan with small and medium-sized enterprises underway at Samsung Group level. Viox is also driving the development of isopropyl alcohol to clean the exterior walls and floors of biopharmaceutical factories based on its experience in detergent development. All of these are also imported from Europe.
CEO Bae said, “In the biopharmaceutical market with high barriers to entry, mutually beneficial growth between large companies and SMEs is more urgent than in any other field,” Bae said. “We will share a good precedent with other companies.”
Reporter Kim Woo-seop [email protected]
